Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 494521 - 494540 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX28 (200MG) PKT | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX14/50MGX14 (250MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX14/50MGX14 (250MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM04) duvelisib (adm: O) | COPIKTRA 15MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular | SecuraBio,Inc. |
| USA | (L01EM04) duvelisib (adm: O) | COPIKTRA 15MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular | SecuraBio,Inc. |
| USA | (L01EM04) duvelisib (adm: O) | COPIKTRA 25MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular | SecuraBio,Inc. |
| USA | (L01EM04) duvelisib (adm: O) | COPIKTRA 25MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular | SecuraBio,Inc. |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01FD01) trastuzumab | HERCESSI 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AccordBioPharma,Inc. |
| USA | (L01FD01) trastuzumab | HERCESSI 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AccordBioPharma,Inc. |
| USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
Pages
